Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.17 USD | +5.52% | +9.81% | +58.44% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 181M | Sales 2025 * | 249M | Capitalization | 609M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | 21M | EV / Sales 2024 * | 3.36 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 * |
-31.7
x | P/E ratio 2025 * |
30.6
x | Employees | 315 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.92% |
Latest transcript on Harrow, Inc.
1 day | +2.73% | ||
1 week | +8.97% | ||
Current month | +72.82% | ||
1 month | +70.64% | ||
3 months | +60.97% | ||
6 months | +87.74% | ||
Current year | +57.23% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 11-11-30 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Director/Board Member | 65 | Jan. 25 | |
Adrienne Graves
BRD | Director/Board Member | 69 | Jan. 25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 17.91 | +4.01% | 121 750 |
24-05-22 | 17.22 | +4.43% | 341,050 |
24-05-21 | 16.49 | -1.79% | 279,299 |
24-05-20 | 16.79 | +0.18% | 332,819 |
24-05-17 | 16.76 | +3.71% | 546,507 |
Delayed Quote OTC Markets, May 23, 2024 at 11:20 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.23% | 609M | |
+39.67% | 723B | |
+34.28% | 595B | |
-3.64% | 369B | |
+20.41% | 332B | |
+2.82% | 282B | |
+17.19% | 244B | |
+9.14% | 208B | |
-5.07% | 205B | |
+0.10% | 168B |
- Stock Market
- Equities
- HROW Stock